March 24, 2009 (FinancialWire) -- Gen-Probe Inc.'s (NASDAQ: GPRO) board has elected Carl W. Hull, the company's current president and chief operating officer, as its new chief executive officer, effective May 18. He also is expected to join the Gen-Probe board at that time.

Hull will become president and CEO following the retirement of Henry L. Nordhoff as the company's CEO on May 17. Nordhoff, who has served as Gen-Probe's chief executive officer since 1994, will become non-executive chairman upon his re-election to the board by stockholders at the company's 2009 annual meeting.

San Diego-based Gen-Probe is engaged in the development, manufacture and marketing of nucleic acid tests that are used primarily to diagnose human diseases and screen donated human blood.

The company employs around 1,000 people.

FinancialWire" ( http://www.financialwire.net ), an independent, proprietary news service of Investrend Communications, Inc., receives no compensation for its news or opinions. Further disclosure is at http://www.investrend.com/articles/secondlevel.asp?level=472 . To contact FinancialWire" write to inquiries@financialwire.net .

Free annual reports for companies mentioned in the news are accessible via http://investrend.ar.wilink.com/?level=279 .

Copyright(C)2009 by financialwire.net, Inc. All rights reserved.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.